Jon Weber

Senior Director Global Market Access Cell & Gene Therapy Therapeutic Area Lead at Bayer

Jon Weber is a Global Market Access Cell & Gene Therapy Therapeutic Area Lead at Bayer.  In this role, Jon is responsible for optimizing access for Bayer’s portfolio of Cell & Gene Therapies by developing and advancing innovative solutions for payers and healthcare systems.  Prior to joining Bayer, Jon worked in a similar capacity as a Global Access Value and Evidence Strategy Lead at bluebird bio and consulted for Pharma/Biotech in many disease areas and treatment modalities while at Putnam Associates and Simon-Kucher & Partners.  Jon earned a PhD in Pathology from the University of Rochester, an MBA from the Simon School of Business, and a BA in Biology from Colby College.